ORKA
Oruka Therapeutics, Inc.
84.50$
+1.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -23.3% | -17.4% | -36.8% | -266.7% | – | +0.0% | +18.8% | – | – | +53.6% | +0.0% | – | |
| – | – | – | – | – | -180.0% | – | – | – | – | – | – | – | |
| – | -85.4% | +251.1% | +11,217.0% | +37.6% | +25.8% | -38.4% | +20.9% | +20.3% | -4.7% | +5.4% | +48.4% | – | |
| – | – | – | +68.9% | +29.7% | +55.1% | -9.1% | -15.9% | +13.2% | +38.1% | +7.3% | -6.0% | – | |
| – | -17.8% | +57.2% | +772.6% | +37.0% | +30.2% | -34.6% | +13.3% | +20.0% | +0.9% | +5.8% | +37.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | +250.5% | -32.8% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.